Trial Details

COMPLETED
Basic Information
Clinical ID c4479
Identifier NCT00460811
Trial Title Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Irritable Bowel Syndrome With Constipation
Interventions DRUG: Linaclotide Acetate|DRUG: Matching placebo
Participant Information
Sponsor Ironwood Pharmaceuticals, Inc.
City Huntsville
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2007-04
Primary Completion Date 2008-02
Completion Date 2008-04